Biology Reference
In-Depth Information
96. Beckman RA, Mildvan AS, Loeb LA. The fidelity of DNA replica-
tion:manganesemutagenesis in vitro.
Biochemistry
1985;24:5810
118. Wilson 3rd DM, Bohr VA. The mechanics of base excision repair,
and its relationship to aging and disease.
DNA Repair (Amst)
2007;6:544
7.
97. Vartanian JP, Sala M, Henry M, Wain-Hobson S, Meyerhans A.
Manganese cations increase the mutation rate of human immu-
nodeficiency virus type 1
ex vivo
.
J Gen Virol
1999;80:1983
e
59.
119. Wilson 3rd DM, Sofinowski TM, McNeill DR. Repair mechanisms
for oxidative DNA damage.
Front Biosci
2003;8:d963
e
81.
120. Barnes DE, Lindahl T. Repair and genetic consequences of
endogenous DNA base damage in mammalian cells.
Annu Rev
Genet
2004;38:445
6.
98. Hays H, Berdis AJ. Manganese substantially alters the dynamics
of translesion DNA synthesis.
Biochemistry
2002;41:4771
e
e
8.
99. Fromant M, Blanquet S, Plateau P. Direct random mutagenesis of
gene-sized DNA fragments using polymerase chain reaction.
Anal Biochem
1995;224:347
e
76.
121. Stivers JT. Extrahelical damaged base recognition by DNA gly-
cosylase enzymes.
Chemistry
2008;14:786
e
93.
122. Schaaper RM, Kunkel TA, Loeb LA. Infidelity of DNA synthesis
associated with bypass of apurinic sites.
Proc Natl Acad Sci, USA
1983;80:487
e
53.
100. Pelletier H, Sawaya MR, Wolfle W, Wilson SH, Kraut J. A struc-
tural basis for metal ion mutagenicity and nucleotide selectivity
in human DNA polymerase beta.
Biochemistry
1996;35:12762
e
91.
123. Narayan S, Jaiswal AS, Balusu R. Tumor suppressor APC blocks
DNA polymerase beta-dependent strand displacement synthesis
during long patch but not short patch base excision repair and
increases sensitivity to methylmethane sulfonate.
J Biol Chem
2005;280:6942
e
77.
101. Copeland WC, Ponamarev MV, Nguyen D, Kunkel TA,
Longley MJ. Mutations in DNA polymerase gamma cause error
prone DNA synthesis in human mitochondrial disorders.
Acta
Biochim Pol
2003;50:155
e
67.
102. Khare V, Eckert KA. The proofreading 3'
e
9.
124. Jankowska AM, Gondek LP, Szpurka H, Nearman ZP, Tiu RV,
Maciejewski JP. Base excision repair dysfunction in a subgroup of
patients with myelodysplastic syndrome.
Leukemia
2008;22:551
e
5' exonuclease
activity of DNA polymerases: a kinetic barrier to translesion
DNA synthesis.
Mutat Res
2002;510:45
e>
54.
103. Liao DF, Chen LL, Peng CY, Zhang J, Li K. Exo
e
8.
125. Stewart DJ. Mechanisms of resistance to cisplatin and carbopla-
tin.
Crit Rev Oncol Hematol
63: 12-31.
126. Chan KK, Zhang QM, Dianov GL. Base excision repair fidelity in
normal and cancer cells.
Mutagenesis
2006;21:173
e
proofreading
polymerases mediate genetic analysis and its application in
biomedical studies.
Acta Pharmacol Sin
2005;26:302
þ
6.
104. Reha-Krantz LJ. DNA polymerase proofreading: Multiple roles
maintain genome stability.
Biochim Biophys Acta
2010;1804:1049
e
8.
127. Hanawalt PC, Spivak G. Transcription-coupled DNA repair: two
decades of progress and surprises.
Nat Rev Mol Cell Biol
2008;
9:958
e
63.
105. Santos ME, Drake JW. Rates of spontaneous mutation in bacte-
riophage T4 are independent of host fidelity determinants.
Genetics
1994;138:553
e
70.
128. van Gent DC, van der Burg M. Non-homologous end-joining,
a sticky affair.
Oncogene
2007;26:7731
e
64.
106. Reha-Krantz LJ. Regulation of DNA polymerase exonucleolytic
proofreading activity: studies of bacteriophage T4 “antimutator”
DNA polymerases.
Genetics
1998;148:1551
e
40.
129. ShrivastavM, DeHaroLP, Nickoloff JA. Regulation ofDNAdouble-
strand break repair pathway choice.
Cell Res
2008;18:134
e
7.
107. Groth P, Ausl¨nder S, Majumder MM, et al. Methylated DNA
causes a physical block to replication forks independently of
damage signalling, O(6)-methylguanine or DNA single-strand
breaks and results in DNA damage.
J Mol Biol
2010;402:70
e
47.
130. Delacˆ te F, Lopez BS. Importance of the cell cycle phase for the
choice of the appropriate DSB repair pathway, for genome
stability maintenance: the trans-S double-strand break repair
model.
Cell Cycle
2008;7:33
e
82.
108. Woodside AM, Guengerich FP. Effect of the O6 substituent on
misincorporation kinetics catalyzed by DNA polymerases at
O(6)-methylguanine and O(6)-benzylguanine.
Biochemistry
2002;
41:1027
e
8.
131. Durant ST, Nickoloff JA. Good timing in the cell cycle for precise
DNA repair by BRCA1.
Cell Cycle
2005;4:1216
e
22.
132. Lilley DM. All change at Holliday junction.
Proc Natl Acad Sci
USA
1997;94:9513
e
38.
109. Ko¸ ON, Phillips Jr WP, Lee K, et al. Role of DNA repair in
resistance to drugs that alkylate O6 of guanine.
Cancer Treat Res
1996;87:123
e
5.
133. Critchlow SE, Jackson SP. DNA end-joining: from yeast to man.
Trends Biochem Sci
1998;23:394
e
8.
134. Motea EA, Berdis AJ. Terminal deoxynucleotidyl transferase: the
story of a misguided DNA polymerase.
Biochim Biophys Acta
2010;1804:1151
e
46.
110. Papait R, Magrassi L, Rigamonti D, Cattaneo E. Temozolomide
and carmustine cause large-scale heterochromatin reorganization
in glioma cells.
Biochem Biophys Res Commun
2009;379:434
e
66.
135. Lieber M. Antibody diversity: a link between switching and
hypermutation.
Curr Biol
2000;10:R798
e
9.
111. Boulton S, Kyle S, Durkacz BW. Mechanisms of enhancement of
cytotoxicity in etoposide and ionising radiation-treated cells by
the protein kinase inhibitor wortmannin.
Eur J Cancer
2000;36:
535
e
800.
136. Barr FG. Translocations, cancer and the puzzle of specificity.
Nat
Genet
2004;19:121
e
4.
137. Friedberg EC, Lehmann AR, Fuchs RP. Trading places: how do
DNA polymerases switch during translesion DNA synthesis?
Mol Cell
2005;18:499
e
41.
112. Anders JC, Grigsby PW, Singh AK. Cisplatin chemotherapy
(without erythropoietin) and risk of life-threatening thrombo-
embolic events in carcinoma of the uterine cervix: the tip of the
iceberg? A review of the literature.
Radiat Oncol
2006;5:14.
113. Passerini P, Ponticelli C. Corticosteroids, cyclophosphamide, and
chlorambucil therapy of membranous nephropathy.
Semin Neph-
rol
2003;23:355
e
505.
138. McCulloch SD, Kunkel TA. Multiple solutions to inefficient lesion
bypass byT7DNApolymerase.
DNARepair (Amst)
2006;5:1373
e
83.
139. Albertella MR, Green CM, Lehmann AR, O'Connor MJ. A role for
polymerase eta in the cellular tolerance to cisplatin-induced
damage.
Cancer Res
2005;9799
e
61.
114. D'Andrea AD. Susceptibility pathways in Fanconi's anemia and
breast cancer.
N Engl J Med
2010;362:1909
e
806.
140. Stass SA, McGraw TP, Folds JD, Odle B, Bollum FJ. Terminal
transferase in acute lymphoblast leukemia in remission.
Am J Clin
Pathol
1981;75:838
e
19.
115. Kee Y, D'Andrea AD. Expanded roles of the Fanconi anemia
pathway in preserving genomic stability.
GenesDev
2010;24:1680
e
40.
141. Friedman HS, Pluda J, Quinn JA, et al. Phase I trial of carmustine
plus O
6
-benzylguanine for patients with recurrent or progressive
malignant glioma.
J Clin Oncol
2000;18:3522
e
94.
116. Modrich P. Mechanisms in eukaryotic mismatch repair.
J Biol
Chem
2006;281:30305
e
9.
117. Li GM. Mechanisms and functions of DNA mismatch repair.
Cell
Res
2008;18:85
e
8.
142. Friedman HS, Keir S, Pegg AE, et al. O
6
-benzylguanine-mediated
enhancement of chemotherapy.
Mol Cancer Ther
2002;1:943
e
e
98.
e
8.
